Rhythm Pharmaceuticals
Price & Volume
Stats
See more52W Range | $45.90-$122.20 |
Market Cap | $7.5B |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $174.3M |
Revenue Growth (YoY) | 54.3% |
Gross Profit (12 Mos) | $155.8M |
Diluted EPS | -$3.10 |
News
See moreYahoo Finance • last month
Sector Update: Health Care Stocks Advance Late Afternoon
Yahoo Finance • last month
Sector Update: Health Care Stocks Rise Thursday Afternoon
Yahoo Finance • last month
Rhythm Pharmaceuticals Announces Preliminary Data from Exploratory Phase 2 Trial that showed Setmelanotide Demonstrated Positive Efficacy Signal in Prader-Willi Syndrome
Yahoo Finance • last month
The Biotech Industry Is Healthier Than Investors Think. These Are the Stocks to Watch.
About
CEO | Dr. David P. Meeker M.D. |
CFO | Mr. Hunter C. Smith M.B.A. |
Address | 222 Berkeley Street, Boston, MA, United States, 02116 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 283 |
